The plan had been that the initial vaccine we would have received would be from China, but then the NRC would receive the starting material for the production of that. Once the NRC's facility was upgraded and available—remembering that was at the very beginning, before NRC's facility was upgraded—they could start manufacturing it to then supply the latter stages of the vaccine needs to the clinical trials in Canada.
On March 11th, 2021. See this statement in context.